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Aspiration thrombectomy during primary percutaneous coronary interven-
tion (p-PCI) in ST elevation myocardial infarction (STEMI) has been pro-
posed to restore myocardial reperfusion. But important controversies remain
concerning the usefulness of thrombectomy to improve this perfusion. Our
objective was to evaluate the impact of manual thrombectomy on the occur-
rence of angiographically visible distal embolization (AVDE) during p-PCI in
STEMI. 346 consecutive patients admitted for STEMI who underwent p-PCI
and thrombectomy were included. Clinical, angiographic and therapeutics
characteristics were assessed. AVDE was defined as an abrupt vessel closure
occurring at any point during the PCI procedure and that was not present at
baseline. Patients were divided into 2 groups: with AVDE (59 patients) and
without AVDE 287 patients. 
Comparing the 2 groups, patients with AVDE were more likely to be older
than 60 year-old (67 vs. 50%; p=0.014), with a higher proportion of women
(34 vs. 20%; p=0,027), of right coronary artery lesion (57 vs. 34.5%;
p=0.001). 
Conversely, smoking and left anterior descending coronary artery lesion
were more frequent in patients without AVDE (respectively 63 vs. 46%;
p=0.014 and 50 vs. 30%; p=0.005). 
Univariate analysis identify age >60 (OR[95% CI]:2.09(1.15-3.78),
p=0.015), female gender (OR[95% CI]:2.02(1.09-3.73), p=0,024), culprit cor-
onary diameter >3mm (OR[95% CI] as predictors of AVDE during p-PCI for
STEMI. 
By multivariate analysis, culprit coronary diameter >3mm (OR[95% CI]:
1.90 (1.01-3.56); p=0.048) and and the right coronary artery culprit lesion site
(OR[95% CI]:2.48(1.36-4.52); p=0.003) were independent factors associated
with AVDE. AVDE complicating p-PCI during STEMI is frequent (17%).
Strikingly we found that successful thrombectomy does not prevent from
AVDE. Conversely, we highlight that patients with culprit coronary artery
diameter >3mm and STEMI due to right coronary artery occlusion are more
likely to develop AVDE. 
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Rationale In France, the transfer of patients with an acute coronary
syndrome (ACS) from one centre to another is usually done by SMUR,
with on-board medical staff. However, SMUR is not always available. In
this study from the RESURCOR network, we investigated clinical out-
comes in ACS patients transferred in private ambulances without on-board
medical staff.
Method In the French Alps, the RESURCOR network arranges “SCA-
Alpes” transfers in private ambulances with no medical doctors on board
but with non-medically trained staff who follow strict management proto-
cols. Ambulances are equipped with an automatic external defibrillator and
patients are not under heart monitoring. These transfers are for patients
returning to one of the five remote hospitals 24-48h after primary percuta-
neous coronary intervention (PCI) and patients with non-ST elevation
myocardial infarction (NSTEMI) transferred from a remote hospital to a
referral hospital (with coronary interventional facilities) within 72h of
symptom onset and returning to the remote hospital 2 hours after PCI.
Data from patients transferred via SCA-Alpes ambulances were collected
retrospectively. The safety endpoint included sudden death or re-transfer
of the patient to the referral hospital <48h after arrival in the remote hos-
pital after PCI.
Results From 2010 to 2013, 579 patients were transferred by SCA-
Alpes ambulances: 89 patients were treated with primary PCI and 490
patients were treated for NSTEMI. The data for these patients are currently
being analysed. 
Conclusions The clinical outcomes of patients with an ACS transferred via
SCA-Alpes private ambulances will be presented at the meeting. 
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Background and aim Outcomes of AMI patients have substantially
improved over the past 2 decades. Whether similar trends are observed in
elderly (≥75 years of age) and younger patients has not been extensively
studied.
Methods We analysed one-year mortality of elderly vs younger patients in
4 nationwide French survey carried out 5 years apart from 1995 to 2010. Con-
secutive STEMI and NSTEMI patients (≤48 hours from onset) were recruited
over one-month periods. Among 10610 patients included in the 4 surveys,
3389 (32%) were aged 75+.
Results From 1995 to 2010, the proportion of 75+ remained stable in
NSTEMI (1995: 36%, 2010: 38%), but decreased in STEMI patients
(1995: 30%, 2010: 25.5%, P=0.006). Use of PCI ≤72 hours of admission
increased from 6.0% to 54.9% in tin the past 15 years he 75+, and from
19% to 77% in the younger pts, use of new anticoagulants increased from
0 to 62% and 0 to 79%, respectively, and use of recommended secondary
prevention medications from 2% to 43% and from 9% to 69% respec-
tively. All clinical outcomes improved both in the 75+ and <75 age groups
(Table). Risk of one-year death in 2010 vs 1995 was HR 0.48 (0.40-0.59)
in the 75+ and HR 0.38 (0.29-0.50) in younger patients. When early use
of PCI, recommended medications and new anticoagulants were added to
the models, survey period was no longer significantly associated with one-
year death.
Conclusion In these 4 nationwide surveys of AMI pts conducted over a
15-year period, outcomes improved markedly in elderly as in younger
patients. Most of the improvement in outcomes appear mediated by improved
early management (use of PCI and medications). 
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